Section II: Analysis of Different Outcomes in Both Study Groups
IOL, hyperstimulation
IOL
As regards mode of delivery, both groups showed high rates of vaginal delivery (82.4% & 87.1% for misoprostol group and oxytocin group respectively) with no significant difference between the two groups (Mode and time of delivery in both groupsBoth groups had similar neonatal outcomes, as there was no significant difference between babies born in both groups as regards birth weight, Apgar scores at 1 and 5 min, and percentage of babies admitted to NICU. Also, both oxytocin and misoprostol seem to be safe agents for IOL, as hyperstimulation only occurred in 3 cases with misoprostol and 2 cases with oxytocin, with no significant difference between them, as shown in Table Neonatal outcomes of both groupsMaternal side effects in both groups